These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 28127997)

  • 1. Investigational drug therapies for the treatment of gastroparesis.
    Sanger GJ; Pasricha PJ
    Expert Opin Investig Drugs; 2017 Mar; 26(3):331-342. PubMed ID: 28127997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
    Stapleton J; Wo JM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: An analysis of the pharmacological rationale for selecting drugs to inhibit vomiting or increase gastric emptying during treatment of gastroparesis.
    Sanger GJ; Andrews PLR
    Aliment Pharmacol Ther; 2023 May; 57(9):962-978. PubMed ID: 36919196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in the treatment of gastroparesis and functional dyspepsia.
    Tack J; Camilleri M
    Curr Opin Pharmacol; 2018 Dec; 43():111-117. PubMed ID: 30245474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
    Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
    Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of treatment for gastroparesis.
    Sarosiek I; Bashashati M; McCallum RW
    Expert Opin Drug Saf; 2016 Jul; 15(7):937-45. PubMed ID: 27031006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroparesis: separate entity or just a part of dyspepsia?
    Stanghellini V; Tack J
    Gut; 2014 Dec; 63(12):1972-8. PubMed ID: 25260920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between gastric motility and nausea: gastric prokinetic agents as treatments.
    Sanger GJ; Broad J; Andrews PL
    Eur J Pharmacol; 2013 Sep; 715(1-3):10-4. PubMed ID: 23831391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives.
    Stevens JE; Jones KL; Rayner CK; Horowitz M
    Expert Opin Pharmacother; 2013 Jun; 14(9):1171-86. PubMed ID: 23663133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
    Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
    Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.
    Sanger GJ; Furness JB
    Nat Rev Gastroenterol Hepatol; 2016 Jan; 13(1):38-48. PubMed ID: 26392067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of severe gastroparesis induced by parasympathetic surge following facial trauma: a case report.
    Haseeb-Ul-Rasool M; Elhawary A; Saha U; Sethi A; Swaminathan G; Abosheaishaa H
    J Med Case Rep; 2024 May; 18(1):248. PubMed ID: 38750592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric electrical stimulation for the treatment of diabetic gastroparesis.
    Guerci B; Bourgeois C; Bresler L; Scherrer ML; Böhme P
    Diabetes Metab; 2012 Nov; 38(5):393-402. PubMed ID: 22742875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
    Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
    Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data.
    Wo JM; Ejskjaer N; Hellström PM; Malik RA; Pezzullo JC; Shaughnessy L; Charlton P; Kosutic G; McCallum RW
    Aliment Pharmacol Ther; 2011 Mar; 33(6):679-88. PubMed ID: 21214610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study.
    Kendall BJ; Kendall ET; Soykan I; McCallum RW
    J Int Med Res; 1997; 25(4):182-9. PubMed ID: 9283990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features.
    Pasricha PJ; Grover M; Yates KP; Abell TL; Bernard CE; Koch KL; McCallum RW; Sarosiek I; Kuo B; Bulat R; Chen J; Shulman RJ; Lee L; Tonascia J; Miriel LA; Hamilton F; Farrugia G; Parkman HP;
    Gastroenterology; 2021 May; 160(6):2006-2017. PubMed ID: 33548234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant gastroparesis: pathogenesis and management of an underrecognized disorder.
    Donthireddy KR; Ailawadhi S; Nasser E; Schiff MD; Nwogu CE; Nava HR; Javle MM
    J Support Oncol; 2007 Sep; 5(8):355-63. PubMed ID: 17944143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prokinetics in diabetic gastroparesis.
    Hejazi RA; McCallum RW; Sarosiek I
    Curr Gastroenterol Rep; 2012 Aug; 14(4):297-305. PubMed ID: 22688694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation and pathophysiology of gastroparesis.
    Nguyen LA; Snape WJ
    Gastroenterol Clin North Am; 2015 Mar; 44(1):21-30. PubMed ID: 25667020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.